Ribosomal protein S6: a potential therapeutic target against cancer?

YW Yi, KS You, JS Park, SG Lee, YS Seong - International journal of …, 2021 - mdpi.com
Ribosomal protein S6 (RPS6) is a component of the 40S small ribosomal subunit and
participates in the control of mRNA translation. Additionally, phospho (p)-RPS6 has been …

Lighting up Nobel Prize-winning studies with protein intrinsic disorder

L Piersimoni, M Abd el Malek, T Bhatia… - Cellular and Molecular …, 2022 - Springer
Intrinsically disordered proteins and regions (IDPs and IDRs) and their importance in biology
are becoming increasingly recognized in biology, biochemistry, molecular biology and …

HIF-1α is a potential molecular target for herbal medicine to treat diseases

RL Li, LY He, Q Zhang, J Liu, F Lu… - Drug design …, 2020 - Taylor & Francis
HIF-1α is an important factor regulating oxygen balance in mammals, and its expression is
closely related to various physiological and pathological conditions of the body. Because …

Molecular Characterization Of Congenital Erythrocytosis And Idiopathic Erythrocytosis Analysed By Next-Generation Sequencing

RS Frias - 2021 - estudogeral.uc.pt
Erythrocytosis or polycythemia is a pathology characterized by a significant increase in
erythrocyte mass (> 125%) as well as an increase in hemoglobin and hematocrit levels to …

[PDF][PDF] The Interplay between MYC and VHL

J Wurth - 2021 - pub.fh-campuswien.ac.at
Aberrant activation of proto-oncogenes and/or deficiency of tumor suppressor genes are
fundamental common denominator of cancers, which trigger altered cell signaling leading to …

Molecular Characterization of Congenital Erythrocytosis and Idiopathic Erythrocytosis Analysed by Next-Generation Sequencing

R da Silva Frias - 2021 - search.proquest.com
Eritrocitose, ou policitemia, é uma patologia caracterizada por um aumento significativo da
massa eritrocitária (> 125%), dos níveis de hemoglobina e hematócrito, em relação aos …